---
title: "Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290102632.md"
description: "Lunai Bioworks secured its first revenue-generating multi-year U.S. defense collaboration with BioSymetrics for AI-enabled chemical threat assessment and formed the Pathfinder Consortium with several universities. Additionally, the company filed a lawsuit alleging naked short selling, seeking expedited discovery to identify parties responsible for 29.6 million failing-to-deliver shares."
datetime: "2026-06-17T20:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290102632.md)
  - [en](https://longbridge.com/en/news/290102632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290102632.md)
generator: "portal-rs"
---

# Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit

**Lunai Bioworks announced its first revenue-generating multi-year U.S. defense collaboration and has initiated expedited discovery in litigation over alleged naked short selling.**

**Key Highlights:**

-   Secured first revenue-generating, multi-year defense collaboration with BioSymetrics for AI-enabled chemical threat assessment.
-   Formed the Pathfinder Consortium with Harvard, Brigham and Women’s, Utah, Purdue and Colorado to strengthen scientific and national-security ties.
-   Augusta platform aligns with 2027 Defense Authorization priorities for AI-enabled high-throughput chemical neurotoxic threat identification.
-   Advancing precision neurology programs and collaborations, including BrainStorm Therapeutics and NIH-supported STTR grant awarded to BioSymetrics ($1.85M).
-   Filed suit alleging naked short selling with expedited discovery after evidence of 29.6M failing-to-deliver shares and extreme intraday volume; discovery underway to identify responsible parties.

Original SEC Filing: Lunai Bioworks Inc. \[ LNAI \] - 8-K - Jun. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [BCLI.US](https://longbridge.com/en/quote/BCLI.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)

## Related News & Research

- [Why Wolfe Research Just Named Nvidia Stock Its Top AI Pick](https://longbridge.com/en/news/296822517.md)
- [A mysterious free AI model is impressing developers. And nobody knows who made it.](https://longbridge.com/en/news/296687985.md)
- [FOCUS-Why Dutch insurers remain on the sidelines as Netherlands pushes defence spending](https://longbridge.com/en/news/296733242.md)
- [Fei-Fei Li says she runs her AI startup like a 'tiger mom'](https://longbridge.com/en/news/296437111.md)
- [Consulting's race to become AI native](https://longbridge.com/en/news/296676838.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**